IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Zelira Therapeutic Ordf

CUSIP: Q9898G102 | 1 institutional holders

Quarters

Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2022

Almanack Investment Partners, Llc.86,083
0.0% of portfolio›$1
StyleTurnoverLocationFiled
Almanack Investment Partners, Llc.
86,083$10.0%ETFMediumNewtown Square, PA2022-05-13